Skip to main content
ViGenCell Inc. logo

ViGenCell Inc. — Investor Relations & Filings

Ticker · 308080 ISIN · KR7308080001 KO Professional, scientific and technical activities
Open in API
Filings indexed 134 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 308080

About ViGenCell Inc.

https://www.vigencell.com/en/

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 91% confidence The document is titled “분기보고서” (Quarterly Report) for the 14th fiscal year 1Q (period: 2026-01-01 to 2026-03-31) and contains extensive business overview, management’s analysis, detailed financial statements, notes, and audit opinions. It is the full interim report itself, not merely an announcement. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s holdings and changes in company shares (e.g., disposal of 30,520 ordinary shares upon executive resignation). This matches an insider/director dealing report. Therefore, it is classified as Director’s Dealing (DIRS).
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 90% confidence The document is a "주식등의 대량보유상황보고서" (large shareholding status report) filed under Korea’s Capital Markets and Financial Investment Business Act, detailing the number of shares held by a major shareholder and related parties, reporting threshold crossings and shareholding changes. This matches the "Major Shareholding Notification" category (MRQ). It is not an earnings release, annual report, or director’s personal dealing report but a statutory disclosure of significant share ownership changes.
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and provides the voting outcomes for each agenda item (approval of financial statements, director remuneration limit, etc.), including vote counts and percentages. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA). It is not providing AGM materials or presentations but the actual voting results.
2026-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company VGENCELL. It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and auditor information. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and submission of the audit report to the regulator, rather than the full annual report document itself. Therefore, it is classified as an Audit Report / Information document. FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2025, submitted by ViGenCell Inc. to the Financial Supervisory Service and Korea Exchange. It contains detailed sections on company overview, business operations, financial statements, management analysis, and governance. This structure and content align perfectly with the definition of an Annual Report (10-K) in the provided schema, as it is the official yearly report covering company activity and full financial performance. FY 2025
2026-03-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.